COMP <GO>
IPAR vs EPC // EV/EBITDA & P/E VALUATION
Interparfums Inc. (NASDAQ) VS. Edgewell Personal Care Company (NYSE) • 15-METRIC TALLY: IPAR 10
— EPC 2
▲ EV/EBITDA & P/E VALUATION LEADER: IPAR
LAST: $116.37 (+0.75%) • MKT CAP: $3.70B
valuation
13.1x
LAST: $28.57 (0.00%) • MKT CAP: $1.32B
valuation
29.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IPAR VS. EPC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IPAR | EPC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.60% | 41.60% | +22.00 | IPAR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.30% | 2.50% | +18.80 | IPAR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 13.1x | 29.4x | -16.30 | IPAR | /valuation <GO> |
| Free Cash Flow Yield | 5.15% | 8.99% | -3.84 | EPC | /fcf-yield <GO> |
| Operating Margin | 18.20% | 4.30% | +13.90 | IPAR | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 1.10% | +12.90 | IPAR | /net-margins <GO> |
| Revenue Growth (YoY) | — | -1.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.78% | 2.23% | +0.55 | IPAR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.36 | 1.58 | +5.78 | IPAR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | IPAR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 55.6 | -3.10 | EPC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.6x | 48.2x | -31.60 | IPAR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.70B | $1.32B | $2.38B | IPAR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IPAR REV | EPC REV | IPAR GROSS % | EPC GROSS % | IPAR FCF | EPC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.49B | $2.22B | 63.6% | 41.6% | $190.5M | $118.4M |
| FY 2024 | $1.45B | $2.25B | 63.9% | 42.4% | $182.9M | -$231.0M |
| FY 2023 | $1.32B | $2.25B | — | — | $105.8M | -$216.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IPAR // BETA —
EPC // BETA —